Category Archives: Pr Newswire

SURVEY SHOWS AUSTRALIANS FEAR DISTRACTION BY CAR TECHNOLOGY AUSTRALIANS NOT READY TO DRIVE ‘HANDS-FREE’

BRISBANE, Australia, Aug. 6, 2024 /PRNewswire/ — A survey of more than 1,000 Australian car owners by insurance provider Budget Direct found three-quarters of respondents (75%) believe that car technology can be distracting. The most distracting car technologies included touchscreens, hands-free mobile phones and speech-to-text systems. Of bigger concern is that over 1 in 10 (16%) reported […]

CSPM Solutions Take Centre Stage in Cloud Security Posture Management

Growing Cloud Complexity Spurs Demand for Comprehensive Security Solutions SAN ANTONIO, Aug. 7, 2024 /PRNewswire/ — As businesses increasingly migrate to the cloud and adopt cloud-native technologies, the complexity and attack surface of their digital environments have expanded dramatically. Recognising the critical need to secure these environments, organisations are turning to Cloud Security Posture Management (CSPM) […]

TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection

Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at ~20% of the oral tacrolimus dose prevented acute rejection and achieved >80% of the previous oral trough blood levels — leading to diminished drug burden 9 out of 9 (100%) patients who completed the 12-week treatment chose to remain on TFF […]

Mersana Therapeutics to Host Second Quarter 2024 Conference Call on August 13, 2024

CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high unmet medical need, today announced that it will provide business updates and report its financial results for the second quarter ended […]

Annovis’ Lead Compound Enhances Cognition Synergistically with GLP-1 Agonist

MALVERN, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) — via IBN – Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced new preclinical data demonstrating the synergistic effect of its lead compound, buntanetap, […]

Science 37 Unveils New Corporate Headquarters in Research Triangle Park, NC

19,000-square-foot facility reflects the company’s recent growth and continued commitment to the region MORRISVILLE, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) — Science 37, a leader in enhancing patient access to clinical trials, today announced the grand opening of its new, 19,000-square-foot corporate headquarters in Morrisville, North Carolina, in the heart of Research Triangle Park. The […]

Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update

Clinical update presented at ASCO 2024 for CRB-701 showed continued differentiated safety and encouraging efficacy in patients with metastatic urothelial cancer or cervical cancer CRB-701 Phase 1 dose escalation underway in USA and Europe for patients with metastatic urothelial cancer and other nectin-4 enriched tumors and is on schedule for completion in Q4 2024 Cash […]

CoinEx Charity: Assisting the Venezuelan Region in Response to Hurricane Beryl’s Disasters

HONG KONG, Aug. 6, 2024 /PRNewswire/ — Recently, Hurricane Beryl, a Category 4 storm, wreaked havoc in the southeastern Caribbean, bringing intense winds and heavy rainfall that resulted in at least six fatalities and severe damage in many areas. In the Cumanacoa region of Venezuela, torrential rains caused rivers to overflow, damaging numerous vehicles and collapsing […]

Samsung Biologics joins the Pharmaceutical Supply Chain Initiative as Supplier Partner

Samsung Biologics to embed PSCI principles into business practices for responsible value chain management Supplier Partnership reaffirms company’s commitment to decarbonize and build resilient supply chains INCHEON, South Korea, Aug. 6, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), announced today that the company has joined the Pharmaceutical Supply […]

Latest Updates of Viva Biotech’s Portfolio Companies

HONG KONG, Aug. 6, 2024 /PRNewswire/ — Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies’ long-term development. This continuous innovation keeps companies up to date and promotes the evolution of R&D and the success of commercialization. Recently, Viva Biotech’s portfolio companies have new updates. Keep reading for […]